Champions Oncology ( NASDAQ:CSBR ) Third Quarter 2025 Results Key Financial Results Revenue: US$17.0m (up 42% from 3Q... HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology ...

We have seen 10 institutional investors add shares of $CSBR stock to their portfolio, and 8 decrease their positions in their most recent quarter.

Market Open. HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end ...